Literatur
- 1
WHO Task Force .
Stroke - 1989. Recommendations on stroke prevention, diagnosis, and therapy. Report
of the WHO Task Force on Stroke and other Cerebrovascular Disorders.
Stroke.
1989;
20
1407-1431
- 2
The European Stroke Initiative .
Recommendations for Stroke Management.
Cerebrovasc Dis.
2000;
10
1-34
- 3
Astrup J, Siesjö B, Symon L.
Thresholds in cerebral ischemia - the ischemic penumbra.
Stroke.
1981;
12
723-725
- 4
Schellinger P D, Fiebach J B, Mohr A. et al .
Thrombolytic therapy for ischemic stroke-A review. Part I-Intravenous thrombolysis.
Crit Care Med.
2001;
29
1812-1818
- 5
Hacke W, Kaste M, Olsen T S. et al .
European Stroke Initiative (EUSI) Recommendations for Stroke Management.
Cerebrovasc Dis.
2000;
in press
- 6
Schellinger P, Steiner T.
Emergency and intensive-care treatment after a stroke. Recommendations of the European
Consensus Group.
Nervenarzt.
1998;
69
530-539
- 7
Broderick J, Brott T, Barsan W. et al .
Blood pressure during the first minutes of focal cerebral ischemia.
Ann Emerg Med.
1993;
22
1438-1443
- 8 Brott T, Fieschi C, Hacke W. General therapy of ischemic stroke. In: Hacke W (ed).
Neurocritical care. Berlin/Heidelberg: Springer-Verlag 1994: 553-577
- 9
Reith J, Jorgensen H S, Pedersen P M. et al .
Body temperature in acute stroke: relation to stroke severity, infarct size, mortality,
and outcome.
Lancet.
1996;
347
422-425
- 10
Grau A J, Buggle F, Hacke W.
Body temperature and infection in acute stroke.
Lancet.
1996;
347
1415-1416
- 11
Weir C J, Murray G D, Dyker A G. et al .
Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results
of a long-term follow up study.
Bmj.
1997;
314
1303-1306
- 12
Albers G W, Amarenco P, Easton J D. et al .
Anthithrombotic and Thrombolytic Therapy for Ischemic Stroke.
Chest.
2001;
119
300S-320S
- 13
Adams Jr H P, Adams R J, Brott T. et al .
Guidelines for the early management of patients with ischemic stroke: a scientific
statement from the stroke council of the american stroke association.
Stroke.
2003;
34
1056-1083
- 14
International Stroke Trial Collaborative Group .
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous
heparin, both or neither among 19 435 patients with acute ischaemic stroke.
Lancet.
1997;
349
1569-1581
- 15 Hacke W. Abciximab in Emergent Stroke Treatment Trial (Abestt). International Stroke
Conference, Phoenix, AZ, USA. February 13th-15th, 2003
- 16
Schellinger P D, Fiebach J B, Ringleb P A. et al .
[Thrombolytic therapy in ischemic stroke].
Nervenarzt.
2001;
72
590-599
- 17
Schellinger P D, Fiebach J B, Mohr A. et al .
Thrombolytic therapy for ischemic stroke-A review. Part II-Intra-arterial thrombolysis,
vertebrobasilar stroke, phase IV trials, and stroke imaging.
Crit Care Med.
2001;
29
1819-1825
- 18
Brandt T, Kummer R von, Muller Kuppers M. et al .
Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization
and outcome.
Stroke.
1996;
27
875-881
- 19 Wardlaw J M, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischaemic stroke
(Cochrane Review). The Cochrane Library. 2002
- 20
Hacke W, Kaste M, Fieschi C. et al .
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric
stroke. The European Cooperative Acute Stroke Study.
JAMA.
1995;
274
1017-1025
- 21
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
.
Tissue plasminogen activator for acute ischemic stroke.
N Engl J Med.
1995;
333
1581-1587
- 22
Hacke W, Kaste M, Fieschi C. et al .
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous
alteplase in acute ischaemic stroke (ECASS II).
Lancet.
1998;
352
1245-1251
- 23
Clark W M, Wissman S, Albers G W. et al .
Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to
5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase
Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Jama.
1999;
282
2019-2026
- 24
Steiner T, Bluhmki E, Kaste M. et al .
The ECASS 3-hour cohort. Secondary analysis of ECASS data by time stratification.
Cerebrovasc Dis.
1998;
8
198-203
- 25
Stingele R, Bluhmki E, Hacke W.
Bootstrap statistics of ECASS II data: just another post hoc analysis of a negative
stroke trial?.
Cerebrovasc Dis.
2001;
11
30-33
- 26
Hacke W, Brott T, Caplan L. et al .
Thrombolysis in acute ischemic stroke: controlled trials and clinical experience.
Neurology.
1999;
53
S3-14
- 27 Brott T G. A combined metaanalysis of NINDS, ECASS I and II, ATLANTIS. International
Stroke Conference, San Antonio, TX, USA. February 7 - 9th, 2002
- 28
Katzan I L, Furlan A J, Lloyd L E. et al .
Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland
area experience.
Jama.
2000;
283
1151-1158
- 29 Kummer R von, Bozzao L, Manelfe C. Early CT diagnosis of hemispheric brain infarction. Heidelberg:
Springer 1995
- 30
Mohr J P, Biller J, Hilal S K. et al .
Magnetic resonance versus computed tomographic imaging in acute stroke.
Stroke.
1995;
26
807-812
- 31
Hacke W, Warach S.
Diffusion-weighted MRI as an evolving standard of care in acute stroke.
Neurology.
2000;
54
1548-1549
- 32
Fiebach J B, Schellinger P D.
Modern Magnetic Resonance Techniques with Stroke.
Nervenarzt.
2002;
73
104-117
- 33
Warach S, Boska M, Welch K M.
Pitfalls and potential of clinical diffusion-weighted MR imaging in acute stroke.
Stroke.
1997;
28
481-482
- 34
Schellinger P D, Fiebach J B, Hacke W.
Imaging-based decision making in thrombolytic therapy for ischemic stroke: present
status.
Stroke.
2003;
34
575-583
- 35
Fiebach J B, Schellinger P D, Jansen O. et al .
CT and diffusion-weighted MR-Imaging in randomized order: DWI results in higher accuracy
and lower interrater variability in the diagnosis of hyperacute ischemic stroke.
Stroke.
2002;
33
2206-2210
- 36
Fiehler J, Fiebach J B, Gass A. et al .
Diffusion Weighted Imaging in Acute Stroke - A Tool of Uncertain Value.
Cerebrovasc Dis.
2001;
14
187-196
- 37
Fiehler J, Foth M, Kucinski T. et al .
Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans.
Stroke.
2002;
33
79-86
- 38
Schellinger P D, Fiebach J B, Jansen O. et al .
Stroke magnetic resonance imaging within 6 hours after onset of hyperacute cerebral
ischemia.
Ann Neurol.
2001;
49
460-469
- 39
Gass A, Röther J, Gaa J.
Diffusion- and Perfusion-Weighted MRI in Cerebral Ischaemia - Part 2: Clinical Applications.
Akt Neurol.
1999;
26
309-317
- 40
Röther J, Gass A, Busch E.
Diffusion- and Perfusion-Weighted MRI in Cerebral Ischaemia - Part 1: Results of Animal
Experiments.
Akt Neurol.
1999;
26
300-308
- 41
Schellinger P D, Jansen O, Fiebach J B. et al .
Monitoring Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis for Acute
Ischemic Stroke with Diffusion and Perfusion MRI.
Stroke.
2000;
31
1318-1328
- 42
Marks M P, Tong D, Beaulieu C. et al .
Evaluation of early reperfusion and IV rt-PA therapy using diffusion- and perfusion-weighted
MRI.
Neurology.
1999;
52
1792-1798
- 43
Kidwell C S, Saver J L, Mattiello J. et al .
Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion
magnetic resonance imaging.
Ann Neurol.
2000;
47
462-469
- 44
Powers W J, Zivin J.
Magnetic resonance imaging in acute stroke: not ready for prime time.
Neurology.
1998;
50
842-843
- 45
Schellinger P D, Jansen O, Fiebach J B. et al .
Feasibility and practicality of MR imaging of stroke in the management of hyperacute
cerebral ischemia.
AJNR Am J Neuroradiol.
2000;
21
1184-1189
- 46
Warach S.
Stroke neuroimaging.
Stroke.
2003;
34
345-347
- 47
Schellinger P D, Fiebach J B, Mohr A. et al .
The role of stroke MRI in intracranial and subarachnoid hemorrhage.
Nervenarzt.
2001;
72
907-917
- 48
Linfante I, Llinas R H, Caplan L R. et al .
MRI features of intracerebral hemorrhage within 2 hours from symptom onset.
Stroke.
1999;
30
2263-2267
- 49
Schellinger P D, Jansen O, Fiebach J B. et al .
A Standardized MRI Stroke Protocol: Comparison with CT in Hyperacute Intracerebral
Hemorrhage.
Stroke.
1999;
30
765-768
- 50
Fiebach J B, Schellinger P D, Gass A. et al .
Stroke MRI is accurate in hyperacute intracerebral hemorrhage. A multicenter study
on the validity of stroke imaging.
Lancet.
2003;
submitted for publication
- 51
Kummer R von, Allen K L, Holle R. et al .
Acute stroke: usefulness of early CT findings before thrombolytic therapy.
Radiology.
1997;
205
327-333
- 52
Jansen O, Schellinger P D, Fiebach J B. et al .
Early recanalization in acute ischemic stroke saves tissue at risk defined by MRI.
Lancet.
1999;
353
2036-2037
- 53
Röther J, Schellinger P D, Gass A. et al .
Effect of Intravenous Thrombolysis on MRI Parameters and Functional Outcome in Acute
Stroke <6h.
Stroke.
2002;
33
2438-2445
- 54 Külkens S, Schwark C, Schellinger P D. et al .Thrombolysis in ischemic stroke 3
to 6 hours after symptom onset using a MR-based algorithm. International Stroke Conference,
Phoenix, AZ, USA. February 13 - 15th, 2003
Priv.-Doz. Dr. med. Peter D. Schellinger
Neurologische Klinik des Universitätsklinikums Heidelberg
Im Neuenheimer Feld 400 - Kopfklinik
69120 Heidelberg
Email: Peter_Schellinger@med.uni-heidelberg.de
